Biotechnology (59) | Share Agreements (59)

Browse by Company

Allogene Therapeutics, Inc. (1)
Amgen Inc. (2)
AmpliPhi Biosciences Corp (1)
Aptose Biosciences Inc. (1)
ARYA Sciences Acquisition Corp II (1)
Athenex, Inc. (2)
BeiGene, Ltd. (7)
Benitec Biopharma Inc. (1)
BICYCLE THERAPEUTICS Ltd (6)
Biohaven Pharmaceutical Holding Co Ltd. (2)
bluebird bio, Inc. (1)
Chardan Healthcare Acquisition Corp. (1)
CLEVELAND BIOLABS INC (1)
CYTORI THERAPEUTICS, INC. (1)
DBV Technologies S.A. (1)
Dicerna Pharmaceuticals Inc (2)
EXICURE, INC. (1)
GeoVax Labs, Inc. (1)
Health Sciences Acquisitions Corp (1)
InMed Pharmaceuticals Inc. (2)
Invitae Corp (1)
Kiniksa Pharmaceuticals, Ltd. (6)
NOVAVAX INC (1)
Opko Health, Inc. (1)
PDL BIOPHARMA, INC. (1)
PharmaCyte Biotech, Inc. (1)
Spero Therapeutics, Inc. (1)
SPHERIX INC (1)
Spinning Eagle Acquisition Corp. (2)
Sunshine Biopharma, Inc (1)
TYME TECHNOLOGIES, INC. (1)
Xenetic Biosciences, Inc. (5)
Xenon Pharmaceuticals Inc. (1)

Recent Contracts

Share Purchase Agreement, dated as of September 8, 2021, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc (Xenon Pharmaceuticals Inc., Filed With SEC on September 8, 2021)
Share Purchase Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc (Spero Therapeutics, Inc., Filed With SEC on August 5, 2021)
Third Amended and Restated 2018 Employee Share Purchase Plan (BeiGene, Ltd., Filed With SEC on August 5, 2021)
Share Purchase Agreement, dated as of August 2, 2021, by and between Immunovant, Inc. and Roivant Sciences Ltd (Health Sciences Acquisitions Corp, Filed With SEC on August 2, 2021)
Amended and Restated Share Purchase Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (CLEVELAND BIOLABS INC, Filed With SEC on August 2, 2021)
Form of Specific Common Share Certificate (InMed Pharmaceuticals Inc., Filed With SEC on July 13, 2021)
Form of Restricted Share Unit Award Agreement (EXICURE, INC., Filed With SEC on May 12, 2021)
2020 Free Share Plan (English translation) (DBV Technologies S.A., Filed With SEC on March 17, 2021)
Offering Document under the 2018 Employee Share Purchase Plan (effective July 1, 2019) (Kiniksa Pharmaceuticals, Ltd., Filed With SEC on February 25, 2021)
Offering Document under the 2018 Employee Share Purchase Plan (effective January 1, 2021) (Kiniksa Pharmaceuticals, Ltd., Filed With SEC on February 25, 2021)